Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 13 - Compounds containing elements of the 7th group of the periodic system
Patents for C07F 13 - Compounds containing elements of the 7th group of the periodic system (3,549)
12/2003
12/24/2003CN1463475A Non-aqueous electrolyte additive for improving safety and lightium ion secondary battery comprising same
12/24/2003CA2493874A1 Use of transition metal complexes with nitrogen-containing polydentate ligands as a bleaching catalyst and bleaching agent composition
12/20/2003CA2424443A1 Chlorin and bacteriochlorin-based difunctional aminophenyl dtpa and n2s2 conjugates for mr contrast media and radiopharmaceuticals
12/18/2003WO2002062398A3 Radioactively labelled conjugates of phosphonates
12/18/2003US20030232012 For use as in vivo contrast media in nuclear spin tomography (MRT), as blood-pool agents and as lymphographic agents
12/17/2003EP1283842B1 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation
12/17/2003EP1278745B1 Sigma-2 receptors as biomarkers of tumor cell proliferation
12/17/2003EP1001752B1 Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals
12/17/2003CN1462491A Non-aqueous electrolyte additive for improving safety and lithium secondary battery comprising the same
12/11/2003WO2003101948A2 Agents for imaging and diagnostic methods using them
12/11/2003US20030228255 Radioactive complex; diagnosis, therapy
12/11/2003CA2488219A1 Agents for imaging and diagnostic methods using them
12/09/2003US6660246 Ligands and metal complexes thereof
12/04/2003WO2003099810A2 Radiopharmaceuticals for imaging infection and inflammation
12/02/2003US6657026 Polymerization catalysts
11/2003
11/27/2003US20030219354 Deactivation pathogens; using riboflavin sensitizers; exposure to light source
11/26/2003EP1364419A2 Polymers having attached luminescent metal complexes and devices made with such polymers
11/25/2003US6653299 Labelled factor XIIIa substrates
11/20/2003US20030216371 Synthetic catalytic free radical scavengers usefuyl as antioxidants for prevention and therapy of disease
11/19/2003EP0733066B1 Pretargeting methods and compounds
11/18/2003US6649582 Iron 2,11-diaza(3.3)(2,6)pyridinophane derivatives; hydrolytic stability
11/13/2003WO2003093412A2 Tumor imaging compounds
11/13/2003WO2003093284A1 Polymetallic molecular complexes used as contrast agents in magnetic image resonance
11/12/2003EP1360004A1 Catalysts
11/11/2003US6646122 Ligand and complex for catalytically bleaching a substrate
10/2003
10/30/2003US20030203828 Discoloration inhibition by mixing detergents containing peroxy compounds with manganese complexes
10/29/2003EP1355913A1 Paramagnetic metal-phthalocyanine complex compounds and contrast agent using the same
10/23/2003WO2003087209A1 Silicone composition which is cross-linkable by dehydrogenization with condensation in the presence of a metallic catalyst
10/23/2003WO2003049850A3 Powder trace element, method and device for making same
10/22/2003EP1353931A1 Transition metal complexes with proton sponges as ligands
10/21/2003CA2093896C Hormone labelling with rhenium and technetium
10/16/2003WO2003084575A1 Pendant fatty acid imaging agents
10/16/2003US20030195111 Polymerization catalysts for olefin polymerization
10/16/2003US20030194365 Method for labelling technetium or rhenium using borohydride exchange resin
10/15/2003CN1449375A Use of pamoic acid or one of derivatives or analogs thereof for preparing a medicament used for treating diseases
10/09/2003US20030191018 Polymerization of olefins
10/08/2003EP1349864A2 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases
10/08/2003EP0626967B1 Process for preparing enantiomerically pure fluorinated epoxychromans
09/2003
09/30/2003US6627176 Therapy; diagnosis
09/25/2003WO2003079737A2 Rhenium compounds and their use in electroluminescent vorrichtungen
09/25/2003WO2003077727A2 Technetium-dipyridine complexes, and methods of use thereof
09/25/2003US20030181317 Metallocenes having two or more different active sites, one of which is coordinated to an unsaturated nitrogenous ligand, e.g., an imine; polymer control; uniformity; highly active; linear low density polyethylene; isotactic polypropylene
09/24/2003EP1346730A1 Pretargeting methods and novel pretargeting conjugates
09/18/2003US20030175596 Organometallic compound which decomposes when overvoltage is applying
09/18/2003US20030175595 Non-aqueous electrolyte additive for improving safety and lithium ion secondary battery comprising the same
09/17/2003EP1343795A1 Preparation of polymerization catalysts
09/17/2003EP0804439B1 Beta, beta '-dihydroxy meso-substituted chlorins, isobacteriochlorins, bacteriochlorins, and methods for making the same from beta ,beta '-unsubstituted tetrapyrrolic macrocycles
09/12/2003WO2003074539A1 Cycloamide-transition metal complexes and bleach catalysts
09/11/2003US20030171582 Rectangular supramolecules
09/10/2003EP1259522B1 Ligand and complex for catalytically bleaching a substrate
09/10/2003EP1187856B1 Transition metal complexes and olefin polymerization process
09/04/2003WO2002031896A3 Polymers having attached luminescent metal complexes and devices made with such polymers
09/04/2003US20030166920 Prismatic supramolecules
09/03/2003EP1041955B1 Use of transition metal complexes for dyeing keratin fibers
09/03/2003EP0966323B1 Catalysts and methods for catalytic oxidation
09/03/2003CN1440415A Process for the preparation of manganese complexes of salen compounds
08/2003
08/28/2003US20030163003 To form transition metal complexes which are used in such as asymmetric hydrogenation of imines, asymmetric hydride transfer reactions, hydrosilylation, hydroboration, hydrovinylation hydroformylation, allylic alkylation, etc.
08/27/2003EP1338337A2 Catalysts and methods for catalytic oxidation
08/27/2003EP1337532A2 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit
08/26/2003US6610805 Catalyst ligands, catalytic metal complexes and processes using same
08/26/2003US6610641 Transition metal complex
08/21/2003WO2003006070A3 Improved chelator conjugates
08/21/2003US20030158393 Radiolabeled chelation compounds used in pharmaceuticals for diagnostic and therapeutic purposes
08/20/2003EP1336613A2 Metal complexes with iminohydroxamic acid as a ligand
08/20/2003EP1102770B1 Paramagnetic 3-,8-substituted deuteroporphyrin derivatives, pharmaceutical preparations containing same, method for producing same and their use in magnetic resonance imaging of necrosis and infarction
08/20/2003CN1118470C Tc-99m labelled Tc-N nucleated isonitrile compound and its preparation and application
08/19/2003US6607710 Provide a bisphosphonic acid derivative and said bisphosphonic acid derivative being labeled with a radioactive nuclide, which has properties of rapid accumulation to the bone and rapid urinary excretion.
08/14/2003WO2003066067A2 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
08/14/2003CA2475209A1 Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
08/13/2003CN1435419A Medical radioactive rhenium-aminophosphonic acid compound and preparing process thereof
08/07/2003US20030148142 Organic electronic device comprising an emitting layer wherein the emitting layer comprises at least one functionalized polymer having a plurality of first-type functional groups and wherein at least a portion of the first-type functional group
08/06/2003CN1434049A Improved method for preparing crosslinke endomarcocyclic compound
08/05/2003US6602441 Bleaching-active metal complexes
07/2003
07/31/2003WO2003062253A1 Metal complexes for use in metathesis
07/31/2003US20030144554 A metal complex oxidation catalysts
07/31/2003US20030144137 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation
07/31/2003CA2473029A1 Ruthenium and osmium carbene complexes for use in metathesis
07/24/2003WO2003059510A2 Manganese(iv) complex salts and their use as oxidation catalysts
07/23/2003EP1329455A1 Metal carbene complexes, methods and intermediates for making them and their use in metathesis reactions
07/09/2003CN1429231A Ligand and complex for catalytically bleaching substate
07/08/2003US6589948 Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases
07/03/2003WO2003053986A1 Use of metal complex compounds as oxidation catalysts
07/03/2003US20030125195 Polymerisation catalysts
07/03/2003US20030124053 Radiopharmaceuticals for imaging infection and inflammation
07/02/2003EP1322653A2 Metal complexes for use in medical and therapeutic applications
07/02/2003EP1062255B1 Homopolymer of ethylene
06/2003
06/25/2003CN1426451A Composition and method for bleaching substrate
06/19/2003WO2003049850A2 Powder trace element, method and device for making same
06/17/2003US6579904 Process for making betaine transition metal complexes for use in animal feed supplements and compositions thereof
06/11/2003CN1423653A Mixed metal alkoxide complexes and polymerization catalysts made therefrom
06/05/2003US20030105306 Transition metal oxo, sulfido and amido complexes as catalysts of nucleophilic addition reactions
06/05/2003US20030104929 Polymerisation catalyst
06/03/2003US6573257 Salen-metal complexes having superoxide, catalase and/or peroxidase activity to treat or prevent diseases from cell or tissue damage
05/2003
05/30/2003WO2003044031A1 Technetium or rhenium complexes, radiopharmaceutical products comprising them
05/29/2003US20030100763 Process for the preparation of manganese complexes of salen compounds
05/29/2003US20030100689 Polymerisation catalyst
05/28/2003EP1206427A4 Chiral ligands, transition-metal complexes thereof and uses thereof in asymmetric reactions
05/27/2003CA2123808C Improved electrochemiluminescent label for dna probe assays
05/22/2003WO2003042135A2 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
05/22/2003CA2466449A1 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 36